Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway

Overview of attention for article published in Frontiers in Aging Neuroscience, February 2021

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

Levodopa-induced dyskinesia: brain iron deposition as a new hypothesis

Article in BioMetals (August 2024)

Indoleamine 2,3-dioxygenase (IDO1) – Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson’s Disease?

Article in International Immunopharmacology (April 2024)

Tianqi Pingchan Granule promotes recovery of glymphatic system function in a rat model of L-DOPA-Induced Dyskinesia

Article in Journal of Traditional and Complementary Medicine (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.